Page 75 - The lraternational Journal of the Royal Society of Thailand.indd
P. 75

The International Journal of the Royal Society of Thailand
                                                                                                Volume XV-2023



                  Introduction
                         This article of “reflections on how to diagnose and classify lymphoma” comes

                  from the author’s personal experience as a hematopathologist for 30 years since
                  finishing training in 1993 at Department of Pathology, Vanderbilt University Medical
                  Center with Professor Dr. Robert D Collins, one of the well-known hematopathologists
                  in the early 1970s for the Lukes-Collins classification for lymphoma (Lukes & Collins,

                  1974). The author has been serving as a hematopathologist at Department of Pathology,
                  Faculty  of  Medicine  Siriraj  Hospital,  Mahidol  University  since  June  1993.  This
                  government-based hospital is the largest hospital in Thailand. Every year, we diagnose
                  approximately 250 new cases of lymphoma at this hospital and nearly 100 consultation

                  cases from other hospitals and private laboratories. The authors has been involving
                  in a good number of publications on lymphoma throughout the ongoing career
                  (Swerdlow et al, 1993; Sukpanichnant et al, 1998; Sukpanichnant, 2004; Sukpanichnant
                  et al, 2004; Pongpruttipan et al, 2012; Intragumtornchai et al, 2018; Sitthinamsuwan

                  et al, 2018; Ngamdamrongkiat et al, 2022; Vangveeravong et al, 2022).


                  Reflections on how to diagnose and classify lymphoma

                         Since the first description and illustration of Reed-Sternberg cells in Hodgkin
                  disease by Dorothy Reed in 1902 (Reed DM, 1902: 133-98), the diagnosis and classification

                  (D&C) of lymphoma have been improved in the past 120+ years. Struggles, however,
                  were encountered by morphology alone without understanding the nature of the
                  lymphoma cells. At one time, lymphoma was defined as a malignancy of lymphatic
                  tissue encompassing varieties of cells, not only lymphoid cells but also mononuclear

                  phagocyte system cells and other supporting cells. Using comparison to the lymphocytes
                  and reticulum cells given to any large mononuclear cells with close relationship to
                  reticulin fibers as highlighted by histochemical stains, e.g., reticulum stain, NHL was
                  once classified into 2 groups – lymphocyte (for the small cells) and reticulum cell (for

                  the large cells) (Sundberg, 1947). Then, misunderstanding continued for nearly a decade
                  when the large lymphoma cells were interpreted as histiocytes (Rappaport, 1966).
                  It took a lot of research works and publications to demonstrate that the reticulum cell
                  sarcoma or histiocytic lymphoma are in fact large lymphoma cells, either of B-cell or

                  T-cell phenotype, in most cases of lymphoma with large cell morphology (Taylor &
                  Hartsock, 2011; Jaffe, 2019).

                         Immunology provides us knowledge and better understanding in normal
                  lymphoid cells and neoplastic ones. Nevertheless, it took time to accept immunologic
                  approach to the D&C of lymphoma. Lukes-Collins classification (1974) and Kiel





                        Sanya Sukpanichnant                                                               67
   70   71   72   73   74   75   76   77   78   79   80